HCPCS Codes Similar to M1232

HCPCS Codes Similar to “M1232” Code.
Patient receives hcv antibody test with reactive result

M1231 Patient receives hcv antibody test with nonreactive result Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1228 Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
M1229 Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1230 Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
M1234 Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result Code added date: 20160928 Code effective date: 20180401 TXT \| PDF \| XML \| JSON
M1233 Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1483 Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON
M1485 Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON	G9452 Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy Code added date: 20150101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
M1235 Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1469 Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON
G9383 Patient received screening for hcv infection within the 12 month reporting period Code added date: 20150101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	G9385 Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons) Code added date: 20150101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON